Shanghai Model Organisms Center, Inc.

Equities

688265

CNE1000055L1

Healthcare Facilities & Services

End-of-day quote Shanghai S.E. Other stock markets 03:30:00 31/05/2024 am IST			5-day change	1st Jan Change
25.6 ^CNY	+2.20%		+1.39%	-33.42%

29/04	Shanghai Model Organisms Center, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
02/04	Tranche Update on Shanghai Model Organisms Center, Inc.'s Equity Buyback Plan announced on February 24, 2024.	CI

Shanghai Model Organisms Center LLC announced that it expects to receive $30 million in funding from Shanghai Model Organisms Center, Inc.

June 07, 2022

Shanghai Model Organisms Center (USA) LLC announced that it will receive $30 million in an equity round of funding on June 7, 2022. The transaction will include participation from returning investor Shanghai Model Organisms Center, Inc. Pursuant to the transaction, registered capital will increase from $1 million to $31 million. The transaction has been approved by investor in its 2nd meeting of the 3rd directorate and does not need the shareholder's approval.

Latest news about Shanghai Model Organisms Center, Inc.

Shanghai Model Organisms Center, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	29/04	CI
Tranche Update on Shanghai Model Organisms Center, Inc.'s Equity Buyback Plan announced on February 24, 2024.	02/04	CI
Shanghai Model Organisms Center, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	25/02	CI
Tranche Update on Shanghai Model Organisms Center, Inc.'s Equity Buyback Plan announced on September 28, 2023.	24/02	CI
Shanghai Model Organisms Center, Inc. announces an Equity Buyback for CNY 30 million worth of its shares.	24/02	CI
Shanghai Model Organisms Center, Inc. authorizes a Buyback Plan.	23/02	CI
Shanghai Model Organisms Center, Inc.'s Equity Buyback announced on September 28, 2023 has closed with 451,318 shares, representing 0.58% for CNY 16.48 million.	22/02	CI
Tranche Update on Shanghai Model Organisms Center, Inc.'s Equity Buyback Plan announced on September 28, 2023.	04/01	CI
Certain A Shares of Shanghai Model Organisms Center, Inc. are subject to a Lock-Up Agreement Ending on 28-DEC-2023.	28/12	CI
Shanghai Model Organisms Center, Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023	30/23/30	CI
Tranche Update on Shanghai Model Organisms Center, Inc.'s Equity Buyback Plan announced on September 28, 2023.	11/23/11	CI
Shanghai Model Organisms Center, Inc. announces an Equity Buyback for CNY 30 million worth of its shares.	28/23/28	CI
Shanghai Model Organisms Center, Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	30/23/30	CI
Shanghai Model Organisms Center, Inc. authorizes a Buyback Plan.	30/23/30	CI
Shanghai Model Organisms Center, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	28/23/28	CI
Shanghai Model Organisms Center, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	27/23/27	CI
Shanghai Model Organisms Center, Inc.(SHSE:688265) added to Shanghai Stock Exchange A Share Index	28/22/28	CI
Shanghai Model Organisms Center, Inc.(SHSE:688265) added to Shanghai Stock Exchange Composite Index	28/22/28	CI
Certain A Shares of Shanghai Model Organisms Center, Inc. are subject to a Lock-Up Agreement Ending on 28-DEC-2022.	28/22/28	CI
Shanghai Model Organisms Center, Inc. Reports Earnings Results for the Nine Months Ended September 30, 2022	28/22/28	CI
Shanghai Model Organisms Center, Inc. Reports Earnings Results for the Half Year Ended June 30, 2022	29/22/29	CI
Shanghai Model Organisms Center, Inc. agreed to acquire Shanghai Zhongyingjian Health Technology Co., Ltd. from Shanghai Qihongxing Logistics Co., Ltd., Shanghai Haihua Environmental Engineering Co., Ltd. and Shanghai Weili Disinfectant Co., Ltd. for approximately CNY 400 million.	19/22/19	CI
Shanghai Zhongyingjian Health Technology Co., Ltd. announced that it expects to receive CNY 196.952858 million in funding from Shanghai Model Organisms Center, Inc.	15/22/15	CI
Shanghai Model Organisms Center LLC announced that it expects to receive $30 million in funding from Shanghai Model Organisms Center, Inc.	07/22/07	CI
Shanghai Model Organisms Center, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	29/22/29	CI

Chart Shanghai Model Organisms Center, Inc.

Duration

Period

Chart Shanghai Model Organisms Center, Inc.

More charts

Company Profile

Shanghai Model Organisms Center Inc is a China-based company mainly engaged in gene modified animal models and related technical services. The Company's businesses include genetically modified animal model, model breeding, feeding service, efficacy evaluation and phenotypic analysis, other model biotechnology services, model purchase and sales business and other businesses. The genetically modified animal model products are divided into customized models and standardized models, mainly including genetically modified mouse models, genetically modified rat models, genetically modified nematode models and genetically modified zebrafish models. The model breeding business refers to the use of genetically modified animal models developed and produced by the issuer or existing genetically modified animal models provided by customers through natural breeding or assisted reproductive breeding.

Sector

Healthcare Facilities & Services

Calendar

28/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Medical & Diagnostic Laboratories

	1st Jan change	Capi.
SHANGHAI MODEL ORGANISMS CENTER, INC.	-33.42%	27Cr
SONIC HEALTHCARE LIMITED	-24.16%	776.06Cr
RADNET, INC.	+68.65%	433.23Cr
SYNLAB AG	-2.98%	264.08Cr
DR. LAL PATHLABS LIMITED	+2.72%	263.49Cr
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	-46.17%	216.15Cr
FLEURY S.A.	-22.12%	146.25Cr
METROPOLIS HEALTHCARE LIMITED	+13.62%	117.04Cr
DIAN DIAGNOSTICS GROUP CO.,LTD.	-43.81%	114.45Cr
VIJAYA DIAGNOSTIC CENTRE LIMITED	+20.41%	100Cr

Medical & Diagnostic Laboratories